ML19114A228
| ML19114A228 | |
| Person / Time | |
|---|---|
| Issue date: | 03/20/2002 |
| From: | Bates A NRC/SECY |
| To: | |
| Chazell, Russell- SECY | |
| References | |
| Download: ML19114A228 (2) | |
Text
1.
UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON MEDICAL USES OF ISOTOPES (Pursuant to Section 9 of Public Law 92-463)
Committee's Official Designation:
Advisory Committee on the Medical Uses of Isotopes
- 2.
Committee's objectives. scope of activities and duties are as follows:
- 3.
- 4.
- 5.
The Committee provides advice, as requested by the Director, Division of Industrial and Medical Nuclear Safety, Office of Nuclear Material Safety and Safeguards, on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy.
Time period (duration of this Committee):
From March 20, 2002, to March 20, 2004 Official to whom this Committee reports:
Donald A. Cool, Director Division of Industrial and Medical Nuclear Safety Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555 Agency responsible for providing necessary support to this Committee:
U.S. Nuclear Regulatory Commission
- 6.
The duties of the Committee are set forth in Item 2 above.
- 7.
Estimated annual direct cost of this Committee:
- a. $160,000.00 (includes travel, per diem, and compensation)
- b. Total staff-year of support: 1.5 FTE
- 8.
Estimated number of meetings per year:
Three meetings per year except when active rulemaking is conducted, then five meetings per year.
- 9.
The Committee's termination date.
March 20, 2004
- 10.
Filing date:
March 20, 2002 a~,,G__)_. ;3;:,~
Andrew L. Bates Advisory Committee Management Officer Office of the Secretary of the Commission